Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3452181000168114 | Buprenorphine/Naloxone 8.6/2.1 (MPL) (buprenorphine 8.6 mg + naloxone 2.1 mg) sublingual tablet, 28 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3452191000168112 | Buprenorphine/Naloxone 8.6/2.1 (MPL) sublingual tablet, 28, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Buprenorphine/Naloxone 8.6/2.1 (MPL) sublingual tablet, 28, blister pack | Is a | Buprenorphine/Naloxone 8.6/2.1 (MPL) sublingual tablet, 28 | true | Inferred relationship | Some | ||
| Buprenorphine/Naloxone 8.6/2.1 (MPL) sublingual tablet, 28, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Buprenorphine/Naloxone 8.6/2.1 (MPL) sublingual tablet, 28, blister pack | has TPUU | Buprenorphine/Naloxone 8.6/2.1 (MPL) sublingual tablet | true | Inferred relationship | Some | 1 | |
| Buprenorphine/Naloxone 8.6/2.1 (MPL) sublingual tablet, 28, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Buprenorphine/Naloxone 8.6/2.1 (MPL) sublingual tablet, 28, blister pack | has TP | Buprenorphine/Naloxone 8.6/2.1 (MPL) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Schedule 8 medications reference set
Containered trade product pack reference set
FHIR